• Evaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium The Netherlands

  • Pharmacokinetics of Nicorandil 40 mg Extended‑Release Capsules in Healthy Volunteers Under Fasting and Fed Conditions

    Not recruiting

    1 1 1
    Portugal

  • Study of Cannabidiol for Treatment of Recurrent Pericarditis in Affected Patients

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Safety, Tolerability and Antiretroviral Activity of a Single Oral Dose of MK-8527 in ART‑Naïve Adults with HIV‑1

    Not recruiting

    1 1 1
    Investigated Diseases:
    Romania

  • Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain

  • Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

    Not recruiting

    1 1 1
    Investigated Drugs:
    Bulgaria Slovakia

  • Safety, Tolerability and Pharmacokinetics of MK-4318 in Healthy Adult Participants for Acute and Chronic Pain

    Not recruiting

    1 1
    Investigated Diseases:
    Belgium

  • Single‑dose Bioavailability of Gliclazide Modified‑Release Tablets in Healthy Volunteers (Type 2 Diabetes)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal

  • Study of BI 1810631 oral bioavailability in healthy men under fed vs fasted conditions

    Not recruiting

    1 1 1
    Investigated Drugs:
    Germany

  • Bioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

powered by